A lactobacilli-based inhaled live biotherapeutic product attenuates pulmonary neutrophilic inflammation
Topics
Bronchopulmonary dysplasia · Live biotherapeutic product · Lactobacillus strains · Acetylated proline-glycine-proline (Ac-PGP) · MMP-9/PGP pathway · Matrix metalloproteinase-9 · Neutrophilic inflammation · Hyperoxia exposure · Volutrauma · Firmicute depletion · Airway microbiome · Chronic obstructive pulmonary disease · Murine model of BPD · Gain- and loss-of-function studies · Inhaled therapeutics · Lung structure and function · Neutrophil chemotaxis · In vitro and in vivo disease models · Bronchopulmonary dysplasia · Pro-inflammatory markers
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026. https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459

